Quoted from http://www.law.com/jsp/article.jsp?id=1202471992353
Bayer Settles Cases Over Clotting Drug
Amaris Elliott-Engel
The Legal Intelligencer
September 14, 2010
Drugmaker Bayer AG has agreed to settle about 200 of 2,000 cases in which plaintiffs alleged that the use of Trasylol to control bleeding during their heart surgeries caused injuries such as kidney failure and fatal heart problems.
One Pennsylvania lawyer, James R. Ronca of Anapol Schwartz Weiss Cohan Feldman & Smalley, said he has settled 39 cases for a total of $19.9 million, which would work out to an average settlement of $510,000.
Ronca, who is co-lead plaintiffs counsel for the Trasylol multidistrict litigation centered in the U.S. District Court for the Southern District of Florida and plaintiffs' liaison counsel for the Philadelphia Common Pleas Court Trasylol mass tort program, said he has settled his entire inventory except for one case. Twenty of the cases were federal cases, and 19 of the cases were state cases.
Bloomberg reported in August that Bayer, which has its U.S. headquarters in Pittsburgh, had agreed to settle 150 cases for $60 million.
Neal L. Moskow of Ury & Moskow in Fairfield, Conn., said that he has settled 60 cases so far in the MDL, but he did not want to release the aggregate amount of the settlements.
Moskow said that the first Trasylol case scheduled to go to trial earlier this year was his firm's case and that case involved a much more serious injury than other plaintiffs'; the plaintiff in that case is on permanent dialysis and now is on the kidney transplant list.